ORX:STO
Orexo AB
SEKÂ 0.88
arrow_upward
+1.27%(+0.011) 1D
Nov 13, 5:29:57 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEKÂ 0.90
High
SEKÂ 0.90
Low
SEKÂ 0.83
Mkt. cap
308.06M
Avg. vol.
739.90K
Volume
1.15M
P/E ratio
0.06
52-wk high
SEKÂ 22.55
52-wk low
SEKÂ 0.80
EPS
SEKÂ 13.61
Shares outstanding
35.13M
No. of employees
55
Open
SEKÂ 0.90
High
SEKÂ 0.90
Low
SEKÂ 0.83
Mkt. cap
308.06M
Avg. vol.
739.90K
Volume
1.15M
P/E ratio
0.06
52-wk high
SEKÂ 22.55
52-wk low
SEKÂ 0.80
EPS
SEKÂ 13.61
Shares outstanding
35.13M
No. of employees
55
News stories
From web sources and news partners
Yahoo Finance
·
23 minutes ago
The S&P 500 Has Gone 18 Months Without a 10% Drop. Here's How the Next Year Has Gone After Streaks This Long.
Bloomberg.com
·
3 hours ago
SpaceX’s S&P 500 Bid Gets New Life as Musk Pitches Tesla Merger
The Motley Fool
·
1 hour ago
Prediction: This Small-Cap Value ETF Will Beat the S&P 500 Over the Next 10 Years
Traders Union
·
1 hour ago
Tom McClellan: NYSE Composite Index better comparison for A-D Line than S&P 500
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com